amrinone has been researched along with Sepsis in 2 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jurasinski, CV | 1 |
Kilpatrick, L | 1 |
Vary, TC | 2 |
2 other studies available for amrinone and Sepsis
Article | Year |
---|---|
Amrinone prevents muscle protein wasting during chronic sepsis.
Topics: Abscess; Adenosine Triphosphate; Amrinone; Animals; Cyclic AMP; Eating; Insulin; Kinetics; Male; Mus | 1995 |
Amrinone prevents the inhibition of muscle pyruvate dehydrogenase complex activity during sepsis.
Topics: Amrinone; Animals; Enzyme Inhibitors; Lactates; Lactic Acid; Least-Squares Analysis; Linear Models; | 1996 |